SCHEMBL5589616

SCHEMBL5589616

CCOC1=C(C)C(=O)C(=O)C(C)=C1OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 3/20 0.41
PTPRC P08575 2/20 0.41
NQO1 P15559 1/20 0.39
MAPT P10636 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PABPC1 P11940 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GRK6 P43250 1/20 0.37
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
RECQL P46063 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587476 0.84 CA12 (0.39) MAPTL3MBTL1KDM4EMEN1KMT2A
SCHEMBL5590411 0.82 CA1 (0.42) MAPTL3MBTL1MEN1KMT2ATDP1
SCHEMBL16260482 0.77 MAPT (0.35) CDC25BPTPRCNQO1MAPTL3MBTL1
SCHEMBL9627838 0.77 CDC25B (0.61) CDC25BPTPRCMAPTL3MBTL1NPSR1
SCHEMBL21796065 0.72 CDC25B (0.41) CDC25BPTPRCNQO1MAPTL3MBTL1
SCHEMBL5590281 0.72 PTPRC (0.34) CDC25BPTPRCNQO1CA12CA1
SCHEMBL3420371 0.72 CDC25B (0.60) CDC25BPTPRCMAPTL3MBTL1NPSR1
SCHEMBL16446931 0.72 KDM4E (0.34) MAPTL3MBTL1NPSR1KDM4EMEN1
SCHEMBL12137192 0.70 PTPRC (0.35) CDC25BPTPRCNQO1MAPTL3MBTL1
SCHEMBL12641814 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 CDC25B 2427/4885PTPRC 4702/4885NQO1 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.